FdaApplication
BLA 761122
Identifiers
- fda_app_no: BLA761122
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2019-06-06 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NUCALA | MEPOLIZUMAB | 100MG | For Injection |
| NUCALA | — | 100MG/ML | Injection |
| NUCALA | — | 40MG/0.4ML | Injection |
| NUCALA | — | 100MG/ML | Injection |
4 products